Thursday December 1st 2022, MyLife Technologies and FARE Capital were happy to welcome PGGM Investments, Stichting Pensioenfonds ING and ROM InWest at Leiden Bio Science Park for a company visit to the health tech startup. A great opportunity to demonstrate the importance of investing in innovative SMEs that are capable of dramatically improving access to […]
About Matthijs Snijder
This author has yet to write their bio.Meanwhile lets just say that we are proud Matthijs Snijder contributed a whooping 17 entries.
Entries by Matthijs Snijder
The FARE Capital Impact Fund has launched through its first investment in My Life Technologies. To earmark this joyful occasion, Mike de Leeuw, CEO of My Life Technologies, sounded the opening bell at Euronext Amsterdam. My Life Technologies is a highly innovative enterprise, that is developing a vaccine technology based on vaccin delivery through ceramic […]
Use restraint when applying the limited amount of company data out there to draw conclusions about Dutch corporate health. Today’s front page article in the FD contains some conclusions that are quite remarkable to say the least. Bankruptcy as a panacea? The article starts out with the bold statement that bankruptcies would actually benefit the […]
Banks can play a vital role in post-pandemic recovery……in their capacity as creditors. An article in today’s FD caught my attention: “Banken willen belang nemen in worstelende bedrijven” (Banks are looking to invest in equity of companies that are struggling). In short, banks are in talks with the Ministry of Finance and Economic Affairs and are […]